1999
DOI: 10.1016/s0960-9822(99)80041-4
|View full text |Cite
|
Sign up to set email alerts
|

A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase

Abstract: These results suggest that, in human cells, the DNA-damage checkpoint involves direct inactivation of Cdc25 catalyzed by Cds1 and/or Chk1.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

8
220
0
2

Year Published

1999
1999
2013
2013

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 258 publications
(230 citation statements)
references
References 50 publications
8
220
0
2
Order By: Relevance
“…In keeping with a defect in the G2 delay, A-T cells do not exhibit a reduction in the activities of the Cdc2 kinase and the Cdc25C phosphatase, shortly after irradiation (Paules et al, 1995;Beamish et al, 1996;Blasina et al, 1999). Accordingly, the rapid modi®cation and activation of Chk2 in response to IR and other DSBs generating agents, but not to UV or HU, is also dependent on ATM (Matsuoka et al, 1998;Brown et al, 1999;Chaturvedi et al, 1999;Uziel, unpublished).…”
Section: G2/m Checkpointmentioning
confidence: 98%
See 2 more Smart Citations
“…In keeping with a defect in the G2 delay, A-T cells do not exhibit a reduction in the activities of the Cdc2 kinase and the Cdc25C phosphatase, shortly after irradiation (Paules et al, 1995;Beamish et al, 1996;Blasina et al, 1999). Accordingly, the rapid modi®cation and activation of Chk2 in response to IR and other DSBs generating agents, but not to UV or HU, is also dependent on ATM (Matsuoka et al, 1998;Brown et al, 1999;Chaturvedi et al, 1999;Uziel, unpublished).…”
Section: G2/m Checkpointmentioning
confidence: 98%
“…Inactivation of Cdc25C is mediated by two protein kinases, Chk1 and Chk2 (HuCds1), which are phosphorylated and activated in response to DNA damage. Chk2 also responds to replication blocks such as those caused by treatment with hydroxyurea (HU) (Sanchez et al, 1997;Matsuoka et al, 1998;Blasina et al, 1999;Brown et al, 1999;Chaturvedi et al, 1999).…”
Section: G2/m Checkpointmentioning
confidence: 99%
See 1 more Smart Citation
“…[1][2][3][4][5][6][7][8] Upon DNA damage, Chk2 is activated by phosphorylation of threonine68 (Thr68) by ATM (ataxiatelangiectasia mutated). [9][10][11][12][13] Activated Chk2 then phosphorylates its downstream effectors, including the tumour suppressors p53, BRCA1, PML, E2F-1, and Cdc25 phosphatases, [14][15][16][17][18][19] thereby regulating cellular responses following DNA damage. Although the molecular basis of Chk2 kinase activation and roles of Chk2 in checkpoint activation are rather well understood, it remains largely unknown as to how activated Chk2 is inhibited to release from checkpoint arrest or to prevent cells from undergoing Chk2-mediated apoptosis.…”
Section: Introductionmentioning
confidence: 99%
“…Phosphorylation of CDC25A promotes its degradation through an ubiquitin-mediated mechanism (Mailand et al, 2000;Falck et al, 2001). Phosphorylation of CDC25C on Ser216 inactivates its phosphatase activity either directly (Blasina et al, 1999a;Furnari et al, 1999) or indirectly through the creation of a 14-3-3 binding site (Peng et al, 1997;Sanchez et al, 1997). Finally, CHK1 is believed to shield centrosomal cyclin B1-CDK1 from unscheduled activation during G 2 phase by phosphorylation of CDC25B and creating a 14-3-3 docking site (Giles et al, 2003;Kramer et al, 2004;Schmitt et al, 2006).…”
Section: Introductionmentioning
confidence: 99%